Aytu Biopharma (AYTU) Return on Capital Employed Growth (5y) (2020 - 2025)
Aytu Biopharma (AYTU) Return on Capital Employed Growth (5y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn |
| 3 | Zoetis | 32.63 Bn | 30.69 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.04 Bn | 20.89 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.34 Bn | 18.54 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.66 Bn | 12.23 Bn | 785.00 Mn |
| 10 | Aytu Biopharma | 21.86 Mn | -4.85 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 106.00 |
| Sep 30, 2025 | 152.00 |
| Jun 30, 2025 | 379.00 |
| Mar 31, 2025 | 2,054.00 |
| Dec 31, 2024 | 3,800.00 |
| Sep 30, 2024 | 6,489.00 |
| Jun 30, 2024 | 5,147.00 |
| Mar 31, 2024 | 4,671.00 |
| Dec 31, 2023 | 6,665.00 |
| Sep 30, 2023 | 9,445.00 |
| Jun 30, 2023 | 8,123.00 |
| Mar 31, 2023 | 6,703.00 |
| Dec 31, 2022 | 1,946.00 |
| Sep 30, 2022 | 849.00 |
| Jun 30, 2022 | 4,670.00 |
| Mar 31, 2022 | 8,399.00 |
| Dec 31, 2021 | 18,179.00 |
| Sep 30, 2021 | 19,220.00 |
| Jun 30, 2021 | -355.00 |
| Dec 31, 2020 | 2,058.00 |